Retroperitoneal endoscopic adrenalectomy is safe and effective

2010 ◽  
Vol 97 (11) ◽  
pp. 1667-1672 ◽  
Author(s):  
J. M. J. Schreinemakers ◽  
G. J. Kiela ◽  
G. D. Valk ◽  
M. R. Vriens ◽  
I. H. M. Borel Rinkes

1998 ◽  
Vol 44 (3) ◽  
pp. 49-53 ◽  
Author(s):  
P. S. Vetshev ◽  
L. I. Ippolitov ◽  
D. I. Gabaidze

The widespread use of endoscopic surgery over the past 10 years is primarily associated with scientific and technological progress, the improvement of endoscopic video equipment, special tools necessary for ultra-precise operating techniques. Some laparoscopic surgeries have already been recognized by experts and are the method of choice in the treatment of a large number of patients, others are still at the stage of clinical trials and a set of sufficient observations to generalize [2, 10, 47].



Reports ◽  
2020 ◽  
Vol 3 (3) ◽  
pp. 22
Author(s):  
Tsuyoshi Nakagawa ◽  
Goshi Oda ◽  
Akihiro Yano ◽  
Hiroshi Kawachi ◽  
Hiroyuki Uetake

Isolated adrenal metastasis of breast cancer is very rare, so adrenalectomy for breast cancer metastasis is rarely performed. The case of a breast cancer patient with five-year survival after resection of a left isolated adrenal metastasis is presented. A 70-year-old woman underwent left modified radical mastectomy and axillary lymphadenectomy for invasive ductal carcinoma (T2N1M0) 9 years earlier. At regular follow-up, a left adrenal mass, 4 cm in diameter, was seen on ultrasound examination and computed tomography (CT). Endoscopic adrenalectomy was performed. Pathological examination confirmed isolated adrenal metastasis of breast cancer. After surgery, hormone therapy was given for 5 years. Ten years after adrenalectomy, no metastatic lesions in other organs have been found on CT. Adrenalectomy for a metastatic adrenal tumor of breast cancer may provide survival benefits when combined with systemic hormone therapy and chemotherapy, particularly in patients with disease confined to the adrenal glands.



1995 ◽  
Vol 82 (2) ◽  
pp. 215-215 ◽  
Author(s):  
A. Heintz ◽  
Th. Junginger ◽  
Th. Böttger


1995 ◽  
Vol 82 (9) ◽  
pp. 1282-1282
Author(s):  
R. S. Taylor ◽  
A. A. Loh ◽  
A. Heintz


2005 ◽  
Vol 19 (8) ◽  
pp. 1086-1092 ◽  
Author(s):  
I. Gockel ◽  
G. Vetter ◽  
A. Heintz ◽  
Th. Junginger


2001 ◽  
Vol 16 (1) ◽  
pp. 96-99 ◽  
Author(s):  
E. Lezoche ◽  
M. Guerrieri ◽  
F. Feliciotti ◽  
A.M. Paganini ◽  
S. Perretta ◽  
...  


2005 ◽  
Vol 19 (11) ◽  
pp. 1491-1497 ◽  
Author(s):  
I. Gockel ◽  
A. Heintz ◽  
R. Kentner ◽  
C. Wetner ◽  
Th. Junginger


2021 ◽  
Vol 91 (9) ◽  
pp. 1655-1658
Author(s):  
Leonardo Rossi ◽  
Lorenzo Fregoli ◽  
Alessandra Bacca ◽  
Sohail Bakkar ◽  
Giampaolo Bernini ◽  
...  


2007 ◽  
Vol 73 (2) ◽  
pp. 174-180 ◽  
Author(s):  
Ines Gockel ◽  
A. Heintz ◽  
M. Polta ◽  
T. Junginger

The long-term effect of adrenalectomy on aldosterone-producing adenomas of the adrenal gland is controversially discussed. The aim of this study was to analyze the long-term course, with special consideration of factors of persisting hypertension after endoscopic adrenalectomy, for Conn's syndrome. Between February 1994 and March 2004, 40 patients with Conn's syndrome underwent endoscopic adrenalectomy. Data were recorded prospectively. Adrenalectomy was carried out unilaterally in all patients. Twenty-three patients (57.5%) were women; the median age was 51.7 (31.2–71.4) years. Preoperatively, all patients presented with arterial hypertension persisting over a median period of 84 (5–240) months; 76.3 per cent of the patients had previously been treated with an aldosterone antagonist, and 85 per cent with specific antihypertensives, whereas 52.6 per cent of all patients were under therapy with potassium compounds at the time of admission. After a median follow-up of 45 (7–114) months, potassium substitution was discontinued in 100 per cent of patients, and the aldosterone antagonist was discontinued in 94.7 per cent of patients. In 60.5 per cent of patients, the specific antihypertensive drugs were reduced. Patients with a reduction in antihypertensive medication had, compared with patients without a reduction, a shorter preoperative duration of arterial hypertension and a lower level of serum aldosterone, and were younger. Endoscopic adrenalectomy for Conn's syndrome leads to an immediate normalization of the electrolyte balance postoperatively, whereas hypertension resolves in 60.5 per cent of patients in the long-term course. Thus, the coexistence of essential hypertension or, respectively, a long duration of preoperative hypertension with associated renovascular alterations are of significance for the long-term result.



Surgery ◽  
2008 ◽  
Vol 144 (6) ◽  
pp. 1008-1015 ◽  
Author(s):  
Celestino Pio Lombardi ◽  
Marco Raffaelli ◽  
Carmela De Crea ◽  
Liliana Sollazzi ◽  
Valter Perilli ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document